Beta Bionics (BBNX) Other Non-Current Liabilities (2023 - 2026)

Beta Bionics has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $1.6 million for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $1.6 million, up 289.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 289.5% YoY), and the FY2025 annual result was $1.5 million, down 96.55% from the prior year.
• Other Non-Current Liabilities came in at $1.6 million for Q1 2026 at Beta Bionics, up from $1.5 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $44.9 million in Q4 2024 to a low of $400000.0 in Q1 2025.
• The 4-year median for Other Non-Current Liabilities is $1.5 million (2025), against an average of $10.4 million.
• Across the five-year window, Other Non-Current Liabilities sank 96.55% in 2025 and soared 289.5% in 2026, its largest moves.
• Beta Bionics' Other Non-Current Liabilities stood at $22.3 million in 2023, then surged by 101.15% to $44.9 million in 2024, then sank by 96.55% to $1.5 million in 2025, then advanced by 0.71% to $1.6 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.6 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.